More on OSTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/13/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

OS Therapies (NY:OSTX)
Delayed: 1.93 --0 (-0%)
Prev. Close $1.93  
Open$1.93 
52 Wk High$ 
52 Wk Low$ 
Day High$1.93 
Day Low$1.93 
P/E N/A  
EPS$ 
Volume1,085 

Friends, Peers and Foes (?): CELC, ONCY, RNXT SLS (more...)

Jun 2, 2026 06:09 AM OS Therapies to report significant survival benefit for OST-HER2 in osteosarcoma
May 19, 2026 08:56 AM OS Therapies, Inc (OSTX) PT Lowered to $13 at Lake Street
May 18, 2026 04:46 PM OS Therapies Incorporated (OSTX) Reports Q1 Loss of $0.27
May 18, 2026 06:05 AM Form 10-Q OS Therapies Inc For: Mar 31
May 15, 2026 06:30 PM Form 5/A OS Therapies Inc For: Dec 31 Filed by: Romness Paul A.
May 15, 2026 04:25 PM Form NT 10-Q OS Therapies Inc For: Mar 31
Apr 30, 2026 04:11 PM Form 8-K OS Therapies Inc For: Apr 30
Apr 30, 2026 06:22 AM EMA initiates rolling review of OS Therapies cancer treatment application
Apr 30, 2026 06:22 AM OS Therapies Announces EMA Initiates Rolling Review of Conditional Marketing Authorization Application for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected Pulmonary Metastatic Oste
Apr 2, 2026 05:25 PM Form 8-K OS Therapies Inc For: Mar 31
View All Articles

Entities mentioned with OSTX

View All Entities